While cell therapies hold great potential for treating many conditions, their utility for treating patients that require whole organ replacement is unclear. To address this challenge, we propose using genetically engineered "organ niches" in large animals to generate human organs from pluripotent stem cells and discuss the hurdles facing such strategies.</p
A major limitation in the field of liver transplantation is the shortage of transplantable organs. C...
Blastocyst complementation combined with gene editing is an emerging approach in the field of regene...
Chimeras are widely acknowledged as the gold standard for assessing stem cell pluripotency, based on...
While cell therapies hold great potential for treating many conditions, their utility for treating p...
New techniques in regenerative medicine may soon enable the creation of human organs inside animals ...
Clinical organ allotransplantation is limited by the availability of deceased human donors. However,...
More than eighteen years have passed since the first derivation of human embryonic stem cells (ESCs)...
In this issue of Stem Cell Reports, Hamanaka et al. (2018) describe the generation of chimeric mice ...
Interspecies blastocyst complementation enables organ-specific enrichment of xenogenic pluripotent s...
International audienceAbstractRecent advances in stem cells and gene engineering have paved the way ...
Interspecies blastocyst complementation enables organ-specific enrichment of xenogenic pluripotent s...
j.stem.2007.07.021mera. If the donor tissue and recipient are of different spe-cies, then an intersp...
Embryonic pluripotency can be recapitulated in vitro by a spectrum of pluripotent stem cell states s...
Abstract: Clinical organ allotransplantation is limited by the availability of deceased human donors...
AbstractOrgan transplantation has been the last line of therapy for saving patients experiencing end...
A major limitation in the field of liver transplantation is the shortage of transplantable organs. C...
Blastocyst complementation combined with gene editing is an emerging approach in the field of regene...
Chimeras are widely acknowledged as the gold standard for assessing stem cell pluripotency, based on...
While cell therapies hold great potential for treating many conditions, their utility for treating p...
New techniques in regenerative medicine may soon enable the creation of human organs inside animals ...
Clinical organ allotransplantation is limited by the availability of deceased human donors. However,...
More than eighteen years have passed since the first derivation of human embryonic stem cells (ESCs)...
In this issue of Stem Cell Reports, Hamanaka et al. (2018) describe the generation of chimeric mice ...
Interspecies blastocyst complementation enables organ-specific enrichment of xenogenic pluripotent s...
International audienceAbstractRecent advances in stem cells and gene engineering have paved the way ...
Interspecies blastocyst complementation enables organ-specific enrichment of xenogenic pluripotent s...
j.stem.2007.07.021mera. If the donor tissue and recipient are of different spe-cies, then an intersp...
Embryonic pluripotency can be recapitulated in vitro by a spectrum of pluripotent stem cell states s...
Abstract: Clinical organ allotransplantation is limited by the availability of deceased human donors...
AbstractOrgan transplantation has been the last line of therapy for saving patients experiencing end...
A major limitation in the field of liver transplantation is the shortage of transplantable organs. C...
Blastocyst complementation combined with gene editing is an emerging approach in the field of regene...
Chimeras are widely acknowledged as the gold standard for assessing stem cell pluripotency, based on...